Over the last few years, Cannatiba has developed this project based on cannabis cultivation behaviour, scientific evidence, market development and collaboration with the Spanish authorities.
Currently, we have applied to be authorised by the AEMPS (Spanish Medicines Agency) to produce the first batches for the validation of the manufacturing process of active pharmaceutical ingredients (APS's) for medical purposes.